SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?


To: vestor who wrote (1828)7/11/2001 10:04:49 PM
From: darbyred  Read Replies (1) | Respond to of 1837
 
Vestor--my opinion has not changed about the merger.

I am delighted to hear that Barr's earnings may exceed analysts expectations. Tamoxifen's lower sales may become a bigger disappointment if the questions about its effectiveness continue.-- I remain a holder of DRMD stock and appreciate your input.